D-1823-2015 Class I Terminated

Recalled by Pharmedium Services, LLC — Lake Forest, IL

FDA drug recall D-1823-2015 was initiated by Pharmedium Services, LLC on Jan 28, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human… The recall status is terminated (terminated Jan 27, 2017). Affected quantity: 20 bags.

Recall Details

Product Type
Drugs
Report Date
Sep 30, 2015
Initiation Date
Jan 28, 2015
Termination Date
Jan 27, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 bags

Product Description

Bupivacaine HCl 0.0625%, 250 mL total volume in a 250 mL LifeCare Bag in Sodium chloride 0.9%, Epidural Use Only, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 36141, NDC# 61553-197-50

Reason for Recall

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Distribution Pattern

Nationwide

Code Information

Lot #: 143140080M, Exp 02/09/15; 143210133M, Exp 02/16/15; 143490031M, Exp 03/16/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1823-2015
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.